Introduction: Icotinib was found to be a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC(50) of 5nM.
NCE Biomedical Co.,Ltd is an innovative biomedical company with independent research and development capacities. It conducts high-level biochemical synthesis with a series of its own intellectual property rights. Our company follows closely the industry trend, and the latest research achievements in life science area. Our main focus is to provide chemical custom synthesis services, and drug synthesis technology optimization services on the new chemical entity (NCE) products; and as well the high...
View more >>
China
